Geriatrics and Aging. 2008;11(6):333-341. Proliferative diabetic retinopathy is clinically characterized by the growth of new blood vessels that arise from the optic disc and/or retina and ...

The following is a summary of “Expanded Field OCT Angiography Biomarkers for Predicting Clinically Significant Outcomes in ...

KOCHI: 68-year-old Thankamma (name changed) from Ernakulam has been a diabetic patient for 15 years. As she did not manage ...

They have just published their study in the international journal Ophthalmic Physiology and Physiological Optics under the ...

November is Eye Disease Month, and there’s a serious condition of the eye that is a leading cause of blindness in people who ...

Welcome to Loukovaara lab web pages! Our main interest is to understand the mechanisms of cell invasion and fibrovascular complications in proliferative diabetic retinopathy and other posterior ...

Treating diabetic retinopathy (DR) is still a significant challenge for clinicians and remains a leading cause of blindness worldwide. NovaGo Therapeutics is developing a human antibody therapy ...

which evaluated the treatment in patients with moderately severe to severe non-proliferative diabetic retinopathy (NPDR). The company had previously reported the success of its phase III DAYLIGHT ...

and due to proliferative diabetic retinopathy. Vision loss due to DR is preventable with the appropriate monitoring and timely treatment. Improved patient and health professional, education to ...